James J Harding (James Harding)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 41

Top Topics

Metastatic Renal Cell Carcinoma

Prognostic Factors

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO precision oncology

Cancer research communications

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Yi Song, Thomas Boerner, Esther Drill, Paul Shin, Sandeep Kumar, Carlie S Sigel, Andrea Cercek, Nancy E Kemeny, Ghassan K Abou-Alfa, Christine A Iacobuzio-Donahue, Darren Cowzer, Nikolaus Schultz, Henry S Walch, Vinod P Balachandran, Bas Groot Koerkamp, Thomas Peter Kingham, Kevin C Soares, Alice C Wei, Michael I D'Angelica, Jeffrey A Drebin, Rohit Chandwani, James J Harding, William R Jarnagin
A Novel Approach to Quantify Heterogeneity of Intrahepatic Cholangiocarcinoma: the Hidden-Genome Classifier. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Ken Zhao, Sam Son, Anita Karimi, Brett Marinelli, Joseph Patrick Erinjeri, Erica S Alexander, Vlasios S Sotirchos, James J Harding, Kevin C Soares, Etay Ziv, Anne Covey, Constantinos T Sofocleous, Hooman Yarmohammadi
Outcomes of Y90 Radioembolization for Hepatocellular Carcinoma in Patients Previously Treated with Transarterial Embolization. Current oncology (Toronto, Ont.) 31 (5) (2024)
Ken Zhao, Sam Son, Anita Karimi, Brett Marinelli, Joseph Patrick Erinjeri, Erica S Alexander, Vlasios S Sotirchos, James J Harding, Kevin C Soares, Etay Ziv, Anne Covey, Constantinos T Sofocleous, Hooman Yarmohammadi
Outcomes of Y90 Radioembolization for Hepatocellular Carcinoma in Patients Previously Treated with Transarterial Embolization. Current oncology (Toronto, Ont.) 31 (5) (2024)
Yi Song, Thomas Boerner, Esther Drill, Paul Shin, Sandeep Kumar, Carlie S Sigel, Andrea Cercek, Nancy E Kemeny, Ghassan K Abou-Alfa, Christine A Iacobuzio-Donahue, Darren Cowzer, Nikolaus Schultz, Henry S Walch, Vinod P Balachandran, Bas Groot Koerkamp, Thomas Peter Kingham, Kevin C Soares, Alice C Wei, Michael I D'Angelica, Jeffrey A Drebin, Rohit Chandwani, James J Harding, William R Jarnagin
A Novel Approach to Quantify Heterogeneity of Intrahepatic Cholangiocarcinoma: The Hidden-Genome Classifier. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Sarah M McIntyre, William A Preston, Henry S Walch, Jeremy Sharib, Ritika Kundra, Carlie Sigel, Michael E Lidsky, Peter J Allen, Michael A Morse, Wei Chen, Andrea Cercek, James J Harding, Ghassan K Abou-Alfa, Eileen M O'Reilly, Wungki Park, Vinod P Balachandran, Jeffrey Drebin, Kevin C Soares, Alice C Wei, T Peter Kingham, Michael I D'Angelica, Christine A Iacobuzio-Donahue, William R Jarnagin
Concordance in Oncogenic Alterations Between the Primary Tumor and Advanced Disease: Insights Into the Heterogeneity of Intrahepatic Cholangiocarcinoma. JCO precision oncology 8 (2024)
Benjamin Garmezy, Mitesh J Borad, Rastislav Bahleda, Cesar A Perez, Li-Tzong Chen, Shumei Kato, Do Youn Oh, Paul Severson, Betty Y Tam, Cheng S Quah, James J Harding
A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors. Cancer research communications 4 (4) (2024)
Yi Song, Thomas Boerner, Esther Drill, Paul Shin, Sandeep Kumar, Carlie S Sigel, Andrea Cercek, Nancy E Kemeny, Ghassan K Abou-Alfa, Christine A Iacobuzio-Donahue, Darren Cowzer, Nikolaus Schultz, Henry S Walch, Vinod P Balachandran, Bas Groot Koerkamp, Thomas Peter Kingham, Kevin C Soares, Alice C Wei, Michael I D'Angelica, Jeffrey A Drebin, Rohit Chandwani, James J Harding, William R Jarnagin
A Novel Approach to Quantify Heterogeneity of Intrahepatic Cholangiocarcinoma: The Hidden-Genome Classifier. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Sarah M McIntyre, William A Preston, Henry S Walch, Jeremy Sharib, Ritika Kundra, Carlie Sigel, Michael E Lidsky, Peter J Allen, Michael A Morse, Wei Chen, Andrea Cercek, James J Harding, Ghassan K Abou-Alfa, Eileen M O'Reilly, Wungki Park, Vinod P Balachandran, Jeffrey Drebin, Kevin C Soares, Alice C Wei, T Peter Kingham, Michael I D'Angelica, Christine A Iacobuzio-Donahue, William R Jarnagin
Concordance in Oncogenic Alterations Between the Primary Tumor and Advanced Disease: Insights Into the Heterogeneity of Intrahepatic Cholangiocarcinoma. JCO precision oncology 8 (2024)
Ken Zhao, Sam Son, Anita Karimi, Brett Marinelli, Joseph Patrick Erinjeri, Erica S Alexander, Vlasios S Sotirchos, James J Harding, Kevin C Soares, Etay Ziv, Anne Covey, Constantinos T Sofocleous, Hooman Yarmohammadi
Outcomes of Y90 Radioembolization for Hepatocellular Carcinoma in Patients Previously Treated with Transarterial Embolization. Current oncology (Toronto, Ont.) 31 (5) (2024)
Darren Cowzer, Joanne F Chou, Henry S Walch, Fergus Keane, Danny Khalil, Jinru Shia, Richard K G Do, Hooman Yarmohammadi, Joseph P Erinjeri, Imane El Dika, Amin Yaqubie, Hassan Azhari, Maya Gambarin, Carla Hajj, Christopher Crane, Alice C Wei, William Jarnagin, David B Solit, Michael F Berger, Eileen M O'Reilly, Nikolaus Schultz, Walid K Chatila, Marinela Capanu, Ghassan K Abou-Alfa, James J Harding
Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapy. The oncologist (2024)
Benjamin Garmezy, Mitesh J Borad, Rastislav Bahleda, Cesar A Perez, Li-Tzong Chen, Shumei Kato, Do Youn Oh, Paul Severson, Betty Y Tam, Cheng S Quah, James J Harding
A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors. Cancer research communications 4 (4) (2024)
William A Preston, Esther Drill, Thomas Boerner, Rebecca Gelfer, James J Harding, Eileen M O'Reilly, Andrea Cercek, Ghassan K Abou-Alfa, Wungki Park, Vinod P Balachandran, Jeffrey Drebin, Kevin C Soares, Alice C Wei, T Peter Kingham, Michael I D'Angelica, William R Jarnagin
Extrahepatic Cholangiocarcinoma: Genomic Variables Associated With Anatomic Location and Outcome. JCO precision oncology 8 (2024)
Petros D Grivas, Elena Garralda, Funda Meric-Bernstam, Ingo K Mellinghoff, Lipika Goyal, James J Harding, Elizabeth C Dees, Rastislav Bahleda, Nilofer S Azad, Asha Karippot, Razelle Kurzrock, Josep Tabernero, Juha Kononen, Matthew Chau Hsien Ng, Rutika Mehta, Nataliya V Uboha, Frédéric Bigot, Valentina Boni, Samantha E Bowyer, Valeriy Breder, Andres Cervantes, Nancy Chan, James M Cleary, Mallika Dhawan, Rikke Helene Løvendahl Eefsen, James Ewing, Donna M Graham, Tormod Kyrre Guren, Jin Won Kim, Krassimir Koynov, Do Youn Oh, Rebecca A Redman, Chia-Jui Yen, David B Spetzler, Marie-Claude Roubaudi-Fraschini, Valérie Nicolas, Rafik Ait-Sarkouh, Claudio Zanna, Abdallah Ennaji, Anna Pokorska-Bocci, Keith T Flaherty
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Benjamin Garmezy, Mitesh J Borad, Rastislav Bahleda, Cesar A Perez, Li-Tzong Chen, Shumei Kato, Do Youn Oh, Paul Severson, Betty Y Tam, Cheng S Quah, James J Harding
A Phase 1 Study of KIN-3248, an irreversible small molecule pan-FGFR inhibitor, in Patients with Advanced FGFR 2/3 Driven Solid Tumors. Cancer research communications (2024)
Sarah M McIntyre, William A Preston, Henry S Walch, Jeremy Sharib, Ritika Kundra, Carlie Sigel, Michael E Lidsky, Peter J Allen, Michael A Morse, Wei Chen, Andrea Cercek, James J Harding, Ghassan K Abou-Alfa, Eileen M O'Reilly, Wungki Park, Vinod P Balachandran, Jeffrey Drebin, Kevin C Soares, Alice C Wei, T Peter Kingham, Michael I D'Angelica, Christine A Iacobuzio-Donahue, William R Jarnagin
Concordance in Oncogenic Alterations Between the Primary Tumor and Advanced Disease: Insights Into the Heterogeneity of Intrahepatic Cholangiocarcinoma. JCO precision oncology 8 (2024)
Benjamin Garmezy, Mitesh J Borad, Rastislav Bahleda, Cesar A Perez, Li-Tzong Chen, Shumei Kato, Do Youn Oh, Paul Severson, Betty Y Tam, Cheng S Quah, James J Harding
A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors. Cancer research communications 4 (4) (2024)
Ken Zhao, Sam Son, Anita Karimi, Brett Marinelli, Joseph Patrick Erinjeri, Erica S Alexander, Vlasios S Sotirchos, James J Harding, Kevin C Soares, Etay Ziv, Anne Covey, Constantinos T Sofocleous, Hooman Yarmohammadi
Outcomes of Y90 Radioembolization for Hepatocellular Carcinoma in Patients Previously Treated with Transarterial Embolization. Current oncology (Toronto, Ont.) 31 (5) (2024)
Yi Song, Thomas Boerner, Esther Drill, Paul Shin, Sandeep Kumar, Carlie S Sigel, Andrea Cercek, Nancy E Kemeny, Ghassan K Abou-Alfa, Christine A Iacobuzio-Donahue, Darren Cowzer, Nikolaus Schultz, Henry S Walch, Vinod P Balachandran, Bas Groot Koerkamp, Thomas Peter Kingham, Kevin C Soares, Alice C Wei, Michael I D'Angelica, Jeffrey A Drebin, Rohit Chandwani, James J Harding, William R Jarnagin
A Novel Approach to Quantify Heterogeneity of Intrahepatic Cholangiocarcinoma: The Hidden-Genome Classifier. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
William A Preston, Esther Drill, Thomas Boerner, Rebecca Gelfer, James J Harding, Eileen M O'Reilly, Andrea Cercek, Ghassan K Abou-Alfa, Wungki Park, Vinod P Balachandran, Jeffrey Drebin, Kevin C Soares, Alice C Wei, T Peter Kingham, Michael I D'Angelica, William R Jarnagin
Extrahepatic Cholangiocarcinoma: Genomic Variables Associated With Anatomic Location and Outcome. JCO precision oncology 8 (2024)
Yi Song, Thomas Boerner, Esther Drill, Paul Shin, Sandeep Kumar, Carlie S Sigel, Andrea Cercek, Nancy E Kemeny, Ghassan K Abou-Alfa, Christine A Iacobuzio-Donahue, Darren Cowzer, Nikolaus Schultz, Henry S Walch, Vinod P Balachandran, Bas Groot Koerkamp, Thomas Peter Kingham, Kevin C Soares, Alice C Wei, Michael I D'Angelica, Jeffrey A Drebin, Rohit Chandwani, James J Harding, William R Jarnagin
A Novel Approach to Quantify Heterogeneity of Intrahepatic Cholangiocarcinoma: the Hidden-Genome Classifier. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
William A Preston, Esther Drill, Thomas Boerner, Rebecca Gelfer, James J Harding, Eileen M O'Reilly, Andrea Cercek, Ghassan K Abou-Alfa, Wungki Park, Vinod P Balachandran, Jeffrey Drebin, Kevin C Soares, Alice C Wei, T Peter Kingham, Michael I D'Angelica, William R Jarnagin
Extrahepatic Cholangiocarcinoma: Genomic Variables Associated With Anatomic Location and Outcome. JCO precision oncology 8 (2024)
Benjamin Garmezy, Mitesh J Borad, Rastislav Bahleda, Cesar A Perez, Li-Tzong Chen, Shumei Kato, Do Youn Oh, Paul Severson, Betty Y Tam, Cheng S Quah, James J Harding
A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors. Cancer research communications 4 (4) (2024)
Kevin C Soares, Joshua S Jolissaint, Sarah M McIntyre, Kenneth P Seier, Mithat Gönen, Carlie Sigel, Naaz Nasar, Andrea Cercek, James J Harding, Nancy E Kemeny, Louise C Connell, Bas Groot Koerkamp, Vinod P Balachandran, Michael I D'Angelica, Jeffrey A Drebin, T Peter Kingham, Alice C Wei, William R Jarnagin
Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival. Cancer medicine (2023)
James J Harding, Sarina A Piha-Paul, Ronak H Shah, Jessica J Murphy, James M Cleary, Geoffrey I Shapiro, David I Quinn, Irene Braña, Victor Moreno, Mitesh Borad, Sherene Loi, Iben Spanggaard, Haeseong Park, James M Ford, Mónica Arnedos, Salomon M Stemmer, Christelle De La Fouchardière, Christos Fountzilas, Jie Zhang, Daniel DiPrimeo, Casey Savin, S Duygu Selcuklu, Michael F Berger, Lisa D Eli, Funda Meric-Bernstam, Komal Jhaveri, David B Solit, Ghassan K Abou-Alfa
Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers. Nature communications 14 (1) (2023)
James J Harding, Sarina A Piha-Paul, Ronak H Shah, Jessica J Murphy, James M Cleary, Geoffrey I Shapiro, David I Quinn, Irene Braña, Victor Moreno, Mitesh Borad, Sherene Loi, Iben Spanggaard, Haeseong Park, James M Ford, Mónica Arnedos, Salomon M Stemmer, Christelle De La Fouchardière, Christos Fountzilas, Jie Zhang, Daniel DiPrimeo, Casey Savin, S Duygu Selcuklu, Michael F Berger, Lisa D Eli, Funda Meric-Bernstam, Komal Jhaveri, David B Solit, Ghassan K Abou-Alfa
Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers. Nature communications 14 (1) (2023)
Perla Chami, Youssef Diab, Danny N Khalil, Hassan Azhari, William R Jarnagin, Ghassan K Abou-Alfa, James J Harding, Joseph Hajj, Jennifer Ma, Maria El Homsi, Marsha Reyngold, Christopher Crane, Carla Hajj
Radiation and Immune Checkpoint Inhibitors: Combination Therapy for Treatment of Hepatocellular Carcinoma. International journal of molecular sciences 24 (23) (2023)
James J Harding, Christiane Jungels, Jean-Pascal Machiels, David C Smith, Chris Walker, Tao Ji, Ping Jiang, Xin Li, Ekaterine Asatiani, Eric Van Cutsem, Ghassan K Abou-Alfa
First-in-Human Study of INCB062079, a Fibroblast Growth Factor Receptor 4 Inhibitor, in Patients with Advanced Solid Tumors. Targeted oncology (2023)
James J Harding, Sarina A Piha-Paul, Ronak H Shah, Jessica J Murphy, James M Cleary, Geoffrey I Shapiro, David I Quinn, Irene Braña, Victor Moreno, Mitesh Borad, Sherene Loi, Iben Spanggaard, Haeseong Park, James M Ford, Mónica Arnedos, Salomon M Stemmer, Christelle De La Fouchardière, Christos Fountzilas, Jie Zhang, Daniel DiPrimeo, Casey Savin, S Duygu Selcuklu, Michael F Berger, Lisa D Eli, Funda Meric-Bernstam, Komal Jhaveri, David B Solit, Ghassan K Abou-Alfa
Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers. Nature communications 14 (1) (2023)
James J Harding, Sarina A Piha-Paul, Ronak H Shah, Jessica J Murphy, James M Cleary, Geoffrey I Shapiro, David I Quinn, Irene Braña, Victor Moreno, Mitesh Borad, Sherene Loi, Iben Spanggaard, Haeseong Park, James M Ford, Mónica Arnedos, Salomon M Stemmer, Christelle De La Fouchardière, Christos Fountzilas, Jie Zhang, Daniel DiPrimeo, Casey Savin, S Duygu Selcuklu, Michael F Berger, Lisa D Eli, Funda Meric-Bernstam, Komal Jhaveri, David B Solit, Ghassan K Abou-Alfa
Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers. Nature communications 14 (1) (2023)
Nicolas A Giraldo, Esther Drill, Baby A Satravada, Imane El Dika, Angela Rose Brannon, Josephine Kam Tai K Dermawan, Abhinita Mohanty, Kerem Ozcan, Debyani Chakravarty, Ryma Benayed, Efsevia Vakiani, Ghassan K Abou-Alfa, Ritika Kundra, Nikolaus Schultz, Bob T Li, Michael F Berger, James J Harding, Marc Ladanyi, Eileen M O'Reilly, William R Jarnagin, Chad M Vanderbilt, Olca Basturk, Maria E Arcila
Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for Intervention. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Valentina Boni, Mary J Fidler, Hendrik-Tobias Arkenau, Alexander Spira, Funda Meric-Bernstam, Nataliya Uboha, Rachel E Sanborn, Randy F Sweis, Patricia LoRusso, Misako Nagasaka, Javier García Corbacho, Shadia Jalal, James J Harding, Stella K Kim, Iris H C Miedema, Danielle J Vugts, Marc C Huisman, Gerben J C Zwezerijnen, Guus A M S van Dongen, Catharina Willemien Menke-van der Houven van Oordt, Song Wang, Tam Dang, Ivan A Zein, Olga Vasiljeva, Susan K Lyman, Virginia Paton, Alison Hannah, Joyce F Liu
Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (10) (2022)
Dazhi Liu, Michael A Weintraub, Christine Garcia, Marcus D Goncalves, Ann Elizabeth Sisk, Alissa Casas, James J Harding, Stephen Harnicar, Alexander Drilon, Komal Jhaveri, James H Flory
Characterization, management, and risk factors of hyperglycemia during PI3K or AKT inhibitor treatment. Cancer medicine 11 (8) (2022)
Funda Meric-Bernstam, Nizar M Tannir, Othon Iliopoulos, Richard J Lee, Melinda L Telli, Alice C Fan, Angela M DeMichele, Naomi B Haas, Manish R Patel, James J Harding, Martin H Voss, Taofeek Kunle Owonikoko, Bradley Carthon, Ramaprasad Srinivasan, Johanna C Bendell, Yonchu Jenkins, Sam H Whiting, Keith Orford, Mark K Bennett, Todd M Bauer
Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (8) (2022)
Joshua S Jolissaint, Kevin C Soares, Kenneth P Seier, Ritika Kundra, Mithat Gönen, Paul J Shin, Thomas Boerner, Carlie S Sigel, Ramyasree Madupuri, Efsevia Vakiani, Andrea Cercek, James J Harding, Nancy E Kemeny, Louise C Connell, Vinod P Balachandran, Michael I D'Angelica, Jeffrey A Drebin, T Peter Kingham, Alice C Wei, William R Jarnagin
Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (14) (2021)
James J Harding, Melinda Telli, Pamela Munster, Martin H Voss, Jeffrey R Infante, Angela DeMichele, Mark Dunphy, Mai H Le, Chris Molineaux, Keith Orford, Frank Parlati, Sam H Whiting, Mark K Bennett, Nizar M Tannir, Funda Meric-Bernstam
A Phase I Dose-Escalation and Expansion Study of Telaglenastat in Patients with Advanced or Metastatic Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (18) (2021)
Parisa Momtaz, Catherine A O'Connor, Joanne F Chou, Marinela Capanu, Wungki Park, Chaitanya Bandlamudi, Michael F Berger, David P Kelsen, Sarah P Suehnholz, Debyani Chakravarty, Kenneth H Yu, Anna M Varghese, Alice Zervoudakis, Jia Li, Geoffrey Y Ku, Jennifer S Park, Marina Shcherba, James J Harding, Zoe Goldberg, Ghassan K Abou-Alfa, Erin E Salo-Mullen, Zsofia K Stadler, Christine A Iacobuzio-Donahue, Eileen M O'Reilly
Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomes. Cancer 127 (23) (2021)
James J Harding, Richard K Do, Amin Yaqubie, Ann Cleverly, Yumin Zhao, Ivelina Gueorguieva, Michael Lahn, Karim A Benhadji, Robin K Kelley, Ghassan K Abou-Alfa
Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinoma. Cancer medicine 10 (9) (2021)
James J Harding, Tsai-Sheng Yang, Yen-Yang Chen, Yin-Hsun Feng, Chia-Jui Yen, Ching-Liang Ho, Wen-Tsung Huang, Imane El Dika, Mehmet Akce, Benjamin Tan, Stacey A Cohen, Timothy Meyer, Debashis Sarker, Dae-Won Lee, Baek-Yeol Ryoo, Ho Yeong Lim, Amanda Johnston, John S Bomalaski, Eileen M O'Reilly, Shukui Qin, Ghassan K Abou-Alfa
Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single-arm, phase 2 study. Cancer 127 (24) (2021)
Imane El Dika, Marinela Capanu, Joanne F Chou, James J Harding, Michele Ly, Anna D Hrabovsky, Richard K G Do, Jinru Shia, Brittanie Millang, Jennifer Ma, Eileen M O'Reilly, Ghassan K Abou-Alfa
Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib. Cancer medicine 9 (20) (2020)
Sebastian P Mondaca, Dazhi Liu, Jessica R Flynn, Sandy Badson, Stefan Hamaway, Mrinal M Gounder, Danny N Khalil, Alexander E Drilon, Bob T Li, Komal L Jhaveri, Alison M Schram, Katherine E Kargus, Mary Kate Kasler, Natalie M Blauvelt, Neil H Segal, Marinela Capanu, Margaret K Callahan, David M Hyman, Maya Gambarin-Gelwan, James J Harding
Clinical implications of drug-induced liver injury in early-phase oncology clinical trials. Cancer 126 (22) (2020)
Maeve A Lowery, Laura W Goff, Bridget P Keenan, Emmet Jordan, Rui Wang, Andrea G Bocobo, Joanne F Chou, Eileen M O'Reilly, James J Harding, Nancy Kemeny, Marianela Capanu, Ann C Griffin, Joseph McGuire, Alan P Venook, Ghassan K Abou-Alfa, Robin Kate Kelley
Second-line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomes. Cancer 125 (24) (2019)